|
Start Date:10/13/2020 Webcast from 8:00 – 10:30 a.m. ET / 2:00 – 4:30 p.m. CET Duration:150 minutes
Agenda:
- Welcome and Introduction Dr. David Horn Solomon CEO of Pharnext 8:00 – 8:15 a.m. ET / 2:00 – 2:15 p.m. CET
- CMT1A Disease Overview Pr. Mario Saporta, M.D. Ph.D. MBA CMT Center of Excellence – University of Miami 8:15 a.m. – 8:55 a.m. ET / 2:15 p.m. – 2:55 p.m. CET
- CMT1A Patient Perspective Allison Moore CEO of the Hereditary Neuropathy Foundation (HNF) 8:55 – 9:20 a.m. ET / 2:55 – 3:20 p.m. CET
- PXT3003 Program Overview Dr. Adrian Hepner CMO of Pharnext 9:20 – 9:50 a.m. ET / 3:20 p.m. – 3:50 p.m. CET
- PleotherapyTM AI Platform Overview Dr. David Horn Solomon 9:50 – 10:05 a.m. ET / 3:50 – 4:05 p.m. CET
- Closing Remarks Dr. David Horn Solomon 10:05 – 10:15 a.m. ET / 4:05 – 4:15 p.m. CET
- Q&A Moderated by Dr. David Horn Solomon 10:05 – 10:15 a.m. ET / 4:05 – 4:15 p.m. CET
Abstract:$-[WCAbstract]-$ If you're already registered for the Pharnext Virtual R&D Day Event webcast, click below: ALREADY REGISTERED? Speakers$-[WCSpeakerDisplayHTML]-$ |
First Name
|
Last Name
|
Email Address
|
Job Title
|
City
|
Country
|
|
|
|
|